drugset / Trial / NCT00429832

A RCT of Ondansetron and Promethazine in the Treatment of Nausea and Vomiting in the Emergency Department

NCT00429832

Phase 4 Completed 120 enrolled University of New Mexico GlaxoSmithKline · collab
RandomizedParallel-groupDouble-blindTreatment

Summary

This was a trial comparing two commonly used medications for nausea and vomiting, ondansetron and promethazine, in the Emergency Department.

Timeline

Start
2003-10
Primary completion
Completion
2005-11

Drugs

EvaluationDrugModalityDoseRoute
Subject Ondansetron Other / unclassified 4 mg Intravenous
Subject Promethazine Small molecule 25 mg Intravenous

Indications

No indication recorded.